EMA Draft questions and answers on Data Monitoring Committees issues

A Supplement to the CHMP Data Monitoring Committee Guideline

The aim of this question-and-answer document is to supplement the CHMP Data Monitoring Committee Guideline (Doc Ref. EMEA/CHMP/EWP/5872/03) by providing clarification on the role and necessity for a Data Monitoring Committee (DMC) in different phases of drug development and throughout the product lifecycle as well as with regard to the responsibilities for implementing DMC decisions.

Read more online
Copyright Widler & Schiemann AG 2015. All Rights Reserved. /